Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting ...

Sarah Bochenick, a health insurance specialist in Harford County, was watching TV with her husband a year ago when she ...

Late-Breaking Science Abstract LB 032 - In a phase III clinical trial in China, stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days starting ...

Understanding seizure causes and their warning signs together with when to seek medical help is crucial because not all ...

An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic ...

Experts at ISC 2026 highlighted growing evidence that GLP-1 receptor agonists may reduce stroke risk and support brain health ...

Harford County woman Sarah Bochenick's stroke recovery story highlights how quick medical response can save lives and prevent ...

HOLLY Brown, 32, endured every parent’s worst nightmare, watching her little girl endure brutal chemotherapy after her ‘heat ...

For infants and toddlers who have had a stroke, a new treatment that restricted the use of their stronger arm and hand to encourage them to use their stroke-affected arm and hand, combined with ...

Breakthrough Phase 2 Trial Results Show Promise for Patients Ineligible for Standard Reperfusion TherapiesData Presented at International Stroke ConferenceData Show That LT3001 Delivers Meaningful ...

By: Dr. Vaibhav Seth As temperatures dip during the winter months, we observe a noticeable rise in stroke cases. In clinical ...

An AI-powered model developed at University of Michigan can read a brain MRI and diagnose a person in seconds, a study suggests. It detected neurological conditions with up to 97.5% accuracy and ...